Casdin Capital Overview

  • Investor Type
  • Hedge Fund
  • Status
  • Active
  • Professionals
  • 8
Professionals
  • Investments
  • 207
  • Portfolio
  • 99
  • Exits
  • 65
Exits

Casdin Capital General Information

Description

Founded in 2012, Casdin Capital is a hedge fund manager based in New York, New York. The firm primarily invests in companies operating in the biotechnology, healthcare, life science, information technology and industrial sectors.

Contact Information

Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
  • 1350 Avenue of the Americas
  • Suite 2600
  • New York, NY 10019
  • United States
+1 (212) 000-0000

Casdin Capital Investments (207)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Creyon Bio 08-Mar-2022 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials
00000000 15-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue
000000 00000000000 09-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue
00000000 27-Jan-2022 00000 00000 00000 Drug Discovery Generating Revenue
000000 0000 25-Jan-2022 00000 00000 00000 Drug Discovery Generating Revenue 000 000000
00000000 24-Jan-2022 0000 00000 Biotechnology Generating Revenue/Not Profitable 000 000000
000 20-Jan-2022 00000 00000 0000 Discovery Tools (Healthcare) Generating Revenue/Not Profitable 00000 000000000 00.0
00000 00000000000 19-Jan-2022 00000 00000 000.00 Discovery Tools (Healthcare) Generating Revenue 00000 000000000 00.0
Verana Health 14-Jan-2022 Later Stage VC 00000 Media and Information Services (B2B) Generating Revenue
Maze Therapeutics 10-Jan-2022 Early Stage VC 00000 Biotechnology Generating Revenue
You’re viewing 10 of 207 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Casdin Capital Exits (65)

Company Name Exit Date Exit Type Exit Size
Amunix Pharmaceuticals 08-Feb-2022 Merger/Acquisition 00.000
000000000 000000 10-Dec-2021 000 000.00
0000000 01-Nov-2021 000 00000
0000000000 01-Oct-2021 000 00000
000000 00000000 00 30-Sep-2021 000 00000
000000 00000000 00 17-Sep-2021 0000000 000000 00.000
000000 00000000000 01-Sep-2021 000000000000000000 000.00
00000000000 30-Aug-2021 000000000000000000
Tango Therapeutics 11-Aug-2021 Reverse Merger 00000
Vividion Therapeutics 01-Aug-2021 Merger/Acquisition 00.00
You’re viewing 10 of 65 exits. Get the full list »

Casdin Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Casdin Capital Team (21)

Name Title Deals Funds Boards Office
Evans Apeadu Chief Financial Officer New York, NY
Lawrence Canzoneri Chief Financial Officer New York, NY
Alexandria Fisk Chief Operating Officer New York, NY
Angelo Crupi Chief Compliance Officer New York, NY
Eli Casdin Founder & Chief Investment Officer 00 0 00 New York, NY
You’re viewing 5 of 21 team members. Get the full list »

Casdin Capital Co-Investors (502)

Name With Exits Lead Partner Series Industry
GV 25 0 0 Series chart Industry bar
Alexandria Venture Investments 00 0 0 Series chart Industry bar
Perceptive Advisors 00 0 0 Series chart Industry bar
Cormorant Asset Management 00 0 0 Series chart Industry bar
Fidelity Management & Research 00 0 0 Series chart Industry bar
You’re viewing 5 of 502 co-investors. Get the full list »